(Q41825220)

English

A novel CUG(exp)·MBNL1 inhibitor with therapeutic potential for myotonic dystrophy type 1.

scientific article published on 20 March 2013

Statements

A novel CUG(exp)·MBNL1 inhibitor with therapeutic potential for myotonic dystrophy type 1. (English)
1 reference
Amin Haghighat Jahromi
1 reference
Lien Nguyen
1 reference
Yuan Fu
1 reference
Kali A Miller
1 reference
Anne M Baranger
1 reference
Steven C Zimmerman
1 reference
20 March 2013
1 reference
1037-1043
1 reference

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit